Recombinant multi-species AICDA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AICDA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a RNA-editing deaminase that is a member of the cytidine deaminase family. AICDA is specifically expressed and active in germinal center-like B cells. In the germinal center, AICDA is involved in somatic hypermutation, gene conversion, and class-switch recombination of immunoglobulin genes. An epigenetic role in neoplastic transformation and lymphoma progression has been experimentally ascribed to AICDA using mouse models. Defects in this gene are the cause of autosomal recessive hyper-IgM immunodeficiency syndrome type 2 (HIGM2). [provided by RefSeq, Jul 2020]
The Alternative Names of target: AICDA,AID,ARP2,Activation-induced cytidine deaminase (AID),Aicda,Aid,Arp2,CDA2,Cytidine aminohydrolase,HEL-S-284,HIGM2,Single-stranded DNA cytosine deaminase,aid
Go
to AICDA products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T36467-Ag-1/ GM-Tg-hg-T36467-Ag-2 | Human AICDA protein | Human |
| GM-Tg-rg-T36467-Ag-1/ GM-Tg-rg-T36467-Ag-2 | Rat AICDA protein | Rat |
| GM-Tg-mg-T36467-Ag-1/ GM-Tg-mg-T36467-Ag-2 | Mouse AICDA protein | Mouse |
| GM-Tg-cynog-T36467-Ag-1/ GM-Tg-cynog-T36467-Ag-2 | Cynomolgus/Rhesus macaque AICDA protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T36467-Ag-1/ GM-Tg-felg-T36467-Ag-2 | Feline AICDA protein | Feline |
| GM-Tg-cang-T36467-Ag-1/ GM-Tg-cang-T36467-Ag-2 | Canine AICDA protein | Canine |
| GM-Tg-bovg-T36467-Ag-1/ GM-Tg-bovg-T36467-Ag-2 | Bovine AICDA protein | Bovine |
| GM-Tg-equg-T36467-Ag-1/ GM-Tg-equg-T36467-Ag-2 | Equine AICDA protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T36467-Ag-1/ GM-Tg-hg-T36467-Ag-2;
GM-Tg-rg-T36467-Ag-1/ GM-Tg-rg-T36467-Ag-2;
GM-Tg-mg-T36467-Ag-1/ GM-Tg-mg-T36467-Ag-2; GM-Tg-cynog-T36467-Ag-1/ GM-Tg-cynog-T36467-Ag-2; GM-Tg-felg-T36467-Ag-1/ GM-Tg-felg-T36467-Ag-2; GM-Tg-cang-T36467-Ag-1/ GM-Tg-cang-T36467-Ag-2; GM-Tg-bovg-T36467-Ag-1/ GM-Tg-bovg-T36467-Ag-2; GM-Tg-equg-T36467-Ag-1/ GM-Tg-equg-T36467-Ag-2 |
| Products Name | AICDA protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | AICDA |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AICDA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.